Science & Research
Quantum BioPharma Ltd. Advances MS Treatment with CDMO Agreement for Lucid-MS
Quantum BioPharma Ltd. has taken a significant step towards clinical trials for its oral Lucid-MS treatment for multiple sclerosis by partnering with a leading contract development and manufacturing organization.
Wearable Devices Ltd. Secures U.S. Patent for Innovative Neural Interface Technology
Wearable Devices Ltd. has been granted a U.S. patent for its gesture and voice-controlled neural interface technology, marking a significant advancement in touchless sensing wearables with applications in XR immersion, industrial efficiency, and assistive solutions for individuals with disabilities.
Study Links Stalking to Increased Risk of Heart Disease and Stroke in Women
New research reveals that women who have experienced stalking or obtained restraining orders face a significantly higher risk of developing heart disease and stroke, highlighting the need for greater awareness and resources to address the health impacts of violence.
Debut Novel 'Die or Not Die' Explores the Intersection of Crime and Cosmic Mystery
Micah Shannon's debut novel, 'Die or Not Die', merges crime thriller with metaphysical inquiry, challenging readers to ponder the rules of death and the afterlife.
Debut Novel 'Echoes of an Unseen Brane' Explores Quantum Physics and Parallel Worlds
Alan Ray Mooso's debut science fiction novel delves into the intersection of quantum theory and human emotion, offering a fresh perspective on reality and identity through the story of a man living two lives across parallel universes.
Nutriband Inc. Advances Toward FDA Approval for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
Nutriband Inc. has secured a Type C Meeting with the FDA for its AVERSA(TM) Fentanyl patch, a significant step towards introducing the world's first abuse-deterrent opioid patch to the market.
Senate Approves Groundbreaking Research on Military Gambling Addiction
The Senate Appropriations Committee has approved a provision to include gambling addiction research in the Department of Defense's Peer-Reviewed Medical Research Program, addressing a critical gap in behavioral health support for servicemembers and veterans.
Breakthrough Lung Cancer Treatment Enhances Chemotherapy with Mitochondrial Transplantation
Researchers in China have developed a novel lung cancer treatment that combines chemotherapy with mitochondrial transplantation to significantly improve treatment efficacy and immune response.
Quantum BioPharma's PET Tracer Shows Promise in Monitoring Myelin Integrity in Multiple Sclerosis
Quantum BioPharma Ltd.'s collaboration with Massachusetts General Hospital has yielded a PET tracer capable of detecting MS lesions invisible to conventional MRI, marking a significant advancement in the monitoring and treatment of multiple sclerosis.
Study Links Ultraprocessed Foods to Increased Health Risks, Calls for Policy Reform
A new Science Advisory from the American Heart Association highlights the adverse health effects of ultraprocessed foods (UPFs), linking them to increased risks of cardiovascular disease, obesity, and diabetes, and calls for research and policy changes to improve public health.
Breakthrough in Graphene Accelerometers Promises Revolution in Miniaturized Sensing Technologies
Researchers have developed a new, highly sensitive graphene-based accelerometer that could transform wearable electronics, medical robotics, and precision instrumentation by offering unparalleled miniaturization and durability.
Girl Scouts of Southeast Florida to Host STEMapalooza 2025: A Gateway to STEM Careers
STEMapalooza 2025 offers an immersive STEM experience, highlighting the importance of science, technology, engineering, and math through interactive learning and discovery.
Safe Pro Group Inc. Expands Global Patent Protection for AI-Based Explosives Detection Technology
Safe Pro Group Inc. secures international patent protection for its SpotlightAI explosives detection technology, enhancing global security measures against explosive threats.
D-Wave Quantum Inc. Unveils Open-Source Toolkit for Quantum AI and Machine Learning
D-Wave Quantum Inc. has launched an open-source toolkit designed to bridge quantum computing with AI and machine learning, marking a significant step towards practical quantum computing applications.
Lantern Pharma Inc. Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule
Lantern Pharma Inc. has successfully completed patient enrollment in Japan for its Phase 2 HARMONIC(TM) trial targeting never-smoker non-small cell lung cancer patients, a significant step towards addressing a critical unmet medical need.
Ireland's Innovative Approach to Renewable Energy: Testing Kites for Wind Power Generation
Researchers in Ireland are exploring the potential of giant kites to generate green electricity, marking a significant step forward in renewable energy innovation.
Soligenix Inc. Highlighted for Innovation in Rare Disease Treatment
Soligenix Inc.'s inclusion in a NetworkNewsWire editorial highlights its HyBryte(TM) platform's potential to address the urgent need for effective therapies in rare diseases, particularly cutaneous T-cell lymphoma, showcasing a commitment to domestic innovation and support for underserved patient populations.
Annovis Bio Inc. Secures Comprehensive Patent Coverage for Buntanetap, Enhancing Treatment Prospects for Neurodegenerative Diseases
Annovis Bio Inc. has expanded its patent portfolio to cover a new crystalline form of buntanetap, promising improved stability and bioequivalence for treating neurodegenerative diseases like Alzheimer's and Parkinson's, with protection extending through 2046.
Cybin Inc. Receives EU Approval for Phase 3 MDD Study, Marking a Significant Step in Mental Health Treatment
Cybin Inc. has secured European approval to commence its EMBRACE Phase 3 study for CYB003, a potential breakthrough in treating Major Depressive Disorder, highlighting a pivotal moment in neuropsychiatry.
Aston Bay Holdings Ltd. Reports Significant Copper Intercepts at Storm Project
Aston Bay Holdings Ltd. announces new copper intercepts at the Storm Copper Project, indicating potential resource expansion and progress in exploration efforts.
GeoVax Advocates for MVA-Based Vaccines Following HHS mRNA Vaccine Rollback
GeoVax Labs highlights the advantages of its MVA-based multi-antigen vaccine, GEO-CM04S1, as a solution to the limitations of mRNA vaccines identified by the HHS, emphasizing broader and more durable protection against COVID-19 and other viruses.
Keystone Capital Launches Gillson Sciences to Advance Human Health Through Scientific Excellence
Keystone Capital Management has established Gillson Sciences, a new entity aimed at providing comprehensive laboratory testing and advisory solutions to enhance product safety and compliance in the healthcare and environmental sectors.
2025 Rose Gala Aims to Elevate Rare Disease Research and Pediatric Care
The 2025 Rose Gala, hosted by the To Cure A Rose Foundation, is set to raise significant funds for rare disease research and honor Dr. Z. Leah Harris for her contributions to pediatric care, featuring auctions and performances to support the cause.
New Genetic Discovery Enhances Cancer Immunotherapy Potential
A groundbreaking genetic discovery could significantly improve the effectiveness of cancer immunotherapy, offering new hope for patients with certain types of cancer.
Lantern Pharma's Starlight Therapeutics Receives FDA Clearance for GBM Combination Trial
Starlight Therapeutics, a subsidiary of Lantern Pharma, has been cleared by the FDA to begin a Phase Ib/2a clinical trial for a novel combination therapy targeting glioblastoma multiforme, a move that could significantly impact treatment options for this aggressive brain cancer.
Soligenix Inc. Advances Rare Disease Treatment with HyBryte Platform, Highlighting Growing Need in Aging Population
Soligenix Inc. is making strides in treating cutaneous T-cell lymphoma, a rare skin cancer affecting older adults, underscoring the urgent need for innovative treatments in the face of an aging population and the prevalence of rare diseases.
Excessive Screen Time Linked to Higher Cardiometabolic Risks in Youth, Study Finds
New research highlights the association between excessive screen time and increased cardiometabolic disease risks in children and young adults, emphasizing the need for balanced daily routines to protect long-term health.
EnPlusOne Biosciences Aims to Revolutionize RNA Therapeutics with Enzymatic Synthesis
EnPlusOne Biosciences, under the leadership of CEO Clare Murray Ph.D., is pioneering an enzymatic approach to RNA synthesis, addressing the limitations of current methods and paving the way for scalable, pure, and environmentally friendly RNA therapeutics.
Quantum BioPharma Ltd. Reports Positive Phase 1 Safety Results for Lucid-MS
Quantum BioPharma Ltd. announces positive Phase 1 safety results for Lucid-MS, a potential treatment for multiple sclerosis, marking a significant step towards efficacy trials and FDA application.
Soligenix Inc. Advances in Rare Disease Therapeutics with HyBryte(TM) Platform
Soligenix Inc. (NASDAQ: SNGX) is making significant strides in the development of treatments for rare diseases, particularly with its HyBryte(TM) platform for cutaneous T-cell lymphoma, addressing a critical need for FDA-approved therapies in an underserved market.